Insight Molecular Diagnostics Inc.
IMDX | NASDAQ
$4.01
+$0.01 (+0.25%)
At close: Sep 21, 2026, 4:00 PM ET
$3.88
-$0.13 (-3.24%)
Pre-market:
Sep 22, 2026, 4:01 AM ET
Market Data
Market Cap $129.48M
Enterprise Value $114.35M
Beta 1.80
Average Volume 291.62K
Shares Outstanding (Diluted) 36.75M
Shares Change YoY 14.76%
Institutional Ownership 54.86%
Exchange NASDAQ
ISIN US68235C2061
Price Performance
Price Change 1M -6.7%
Price Change 3M -25.3%
Price Change 6M -3.1%
Price Change YTD -44.0%
Price Change 1Y 22.6%
Price Change 3Y 25.9%
Price Change 5Y -94.6%
1M CAGR (ann.) -17.0%
1Y CAGR (ann.) 19.0%
5Y CAGR (ann.) -44.5%
All-Time CAGR -29.1%
Valuation
PE Ratio -2.64
Forward PE N/A
PEG Ratio -0.03
Forward PEG 0.55
PS Ratio 77.54
Forward PS 19.30
PB Ratio -6.08
P/FCF Ratio -4.19
P/Adj. FCF Ratio -3.87
P/OCF Ratio -5.49
EV/Sales 68.47
EV/EBIT -2.32
EV/EBITDA -2.44
EV/FCF -3.70
Earnings Yield -37.9%
FCF Yield -23.8%
Adj. FCF Yield -25.8%
Financial Health
Net Cash $15.13M
Total Debt $2.63M
Cash & Short-Term Investments $17.76M
Total Assets $29.44M
Current Ratio 2.00
Quick Ratio 1.98
Debt / Equity Ratio -0.12
Debt / EBITDA -0.06
Debt / FCF -0.09
OCF / Debt -10.27
Interest Coverage -436.03
Altman Z-Score -23.31
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 11.2%
Operating Profit Margin -2558.7%
EBITDA Margin -2803.5%
Net Profit Margin -2955.6%
FCF Margin -1848.8%
Adj. FCF Margin -2001.9%
SBC / Revenue 150.8%
SBC Impact (per share) -8.3%
Returns
Return on Assets -167.6%
Return on Equity 271.8%
Return on Invested Capital -204.8%
Return on Capital Employed -223.1%
Return on Tangible Assets -167.6%
Historical Growth (CAGR)
Revenue CAGR 3Y 14.9%
Revenue CAGR 5Y -16.9%
Revenue CAGR 10Y 18.5%
EPS CAGR 3Y 44.4%
EPS CAGR 5Y 48.1%
EPS CAGR 10Y 10.8%
FCF CAGR 3Y -28.8%
FCF CAGR 5Y 14.3%
FCF CAGR 10Y -7.8%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 11
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 8, 2026
EPS Estimate (next Q) -$0.24
EPS Growth Est (next Q) -30.5%
Revenue Est (next Q) $215.12K
Revenue Growth Est (next Q) -17.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $9.75
Price Target Upside 143.1%
Cash Flow
Operating Cash Flow $-26.95M
Free Cash Flow $-30.88M
Adj. Free Cash Flow $-33.43M
FCF Per Share -$0.84
OCF Per Share -$0.73
OCF/S Ratio -1614.0%
Income Statement
Revenue $1.67M
Gross Profit $186.5K
Operating Income $-42.73M
EBITDA $-46.82M
Net Income $-49.36M
EPS (Diluted) -$1.52
Revenue / Employee $29.3K
Profit / Employee $-865.95K
Employees 57
Add to Watchlist
Select watchlists to add or remove IMDX